tbuckley/cabot-search huggingface dataset:
Targeting HDAC3 in <i>CREBBP</i>-Mutant Lymphomas Counterstrikes Unopposed Enhancer Deacetylation of B-cell Signaling and Immune Response Genes
Authors: Uta E. Höpken
Journal: Cancer Discovery (2017)

Abstract Summary: The cellular phenotype of B-cell lymphomas arising from B cells undergoing germinal center reactions, such as follicular lymphoma and diffuse large B-cell lymphoma, is strongly shaped by mutations in chromatin-modifying genes. The work presented by Jiang and colleagues addresses how somatic mutations in CREBBP disable acetylation and cause unopposed deacetylation by BCL6/SMRT/HDAC3 complexes on enhancers of B-cell signaling and immune response genes. This opens a therapeutic avenue toward targeted inhibition of CREBBP-mutant lymphomas by HDAC inhibitors. Cancer Discov; 7(1); 14–6. ©2017 AACR. See related article by Jiang et al., p. 38.
P3.03-038 Improving Quality of Care and Outcomes for Patients Diagnosed with Pleural Mesothelioma in England
Authors: Susan Harden, Paul Beckett, Aamir Khakwani, Rosie Dickinson, Natasha Wood, Doug West, Neal Navani, Richard Hubbard, Ian Woolhouse
Journal: Journal of Thoracic Oncology (2017)
Involved Field Radiotherapy Versus No Further Treatment in Patients with Clinical Stages IA and IIA Hodgkin Lymphoma and a ‘Negative’ PET Scan After 3 Cycles ABVD. Results of the UK NCRI RAPID Trial
Authors: John Radford, Sally Barrington, Nicholas Counsell, Ruth Pettengell, Peter Johnson, Jennie Wimperis, Stewart Coltart, Dominic Culligan, Andrew Lister, Eric Bessell, Anton Kruger, Bilyana Popova, Barry Hancock, Peter Hoskin, Timothy Illidge, Michael O'Doherty
Journal: Blood (2012)
P2.03b-008 The Impact of Brain Metastases and Their Treatment on Health Utility Scores in Molecular Subsets of Lung Cancer Patients
Authors: Grainne O'Kane, Catherine Labbe, Susie Su, Brandon Tse, Vivian Tam, Tiffany Tse, Mark Doherty, Erin Stewart, Catherine Brown, Andrea Perez Cosio, Devalben Patel, Mindy Liang, Gurshuran Gill, Alexandra Rett, Yvonne Leung, Hilten Naik, Lawson Eng, Nicole Mittmann, Natasha Leighl, Ronald Feld, Penelope Bradbury, Frances Shepherd, Wei Xu, Doris Howell, Geoffrey Liu
Journal: Journal of Thoracic Oncology (2017)
New Tool to Study Zika Virus
Authors: Rebecca Voelker
Journal: JAMA (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
P164 Changing patterns of the use of lung biopsy in interstitial lung disease
Authors: L Brockbank, E Hilal, J Holemans, J Greenwood, M Walshaw, K Mohan
Journal: Thorax (2016)

<h3>Introduction</h3> Radiological and international guidelines have improved the diagnosis of interstitial lung disease (ILD) subtype in the absence of a surgical lung biopsy (SBx). However, it may still be needed since up to 38% of cases<sup>1</sup> cannot be diagnosed on clinical and radiological grounds alone, and new antifibrotic therapies require more diagnostic certainty for idiopathic pulmonary fibrosis (IPF). We wished to ascertain whether SBx rates and diagnostic outcomes had changed at our regional thoracic centre. <h3>Methods</h3> We looked at 104 consecutive patients undergoing SBx between May 2014 to April 2016, and compared their mode of referral and outcome with a previous study (210 cases) in the same centre conducted between 2001 and 2008. <h3>Results</h3> There was no evidence of multidisciplinary team (MDT) input prior to SBx in 31 cases (30%), but 18 (17%) were discussed at an ILD MDT and 55 (53%) in local radiology meetings. For SBx outcome see Table. Prior diagnosis was uncertain in 28% of ILD MDT cases and 27% of local radiology meeting cases, whereas SBx confirmed the suspected diagnosis in 22% of ILD MDT cases but only 9% of radiology meeting cases. <h3>Conclusion</h3> Overall, there appears to be increase in the ILD cases referred for SBx. Despite the small proportion of cases discussed at the ILD MDT prior to SBx, there appears to be a trend in the reduction of UIP/NSIP and significant increase in HSP, RBILD and DIP cases. Histological diagnosis remains important in ILD, and the use of other techniques with lower complication rates (e.g. transbronchial cryobiopsy) needs to be established. <h3>Reference</h3> Raghu G, Mageto YN, Lockhart D, <i>et al</i>. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease. A prospective study. <i>Chest</i> 1999;<b>116</b>:1168–1174.
OA10.01 Comprehensive Genomic Profiling and PDX Modeling of EGFR Exon 20 Insertions: Evidence for Osimertinib Based Dual EGFR Blockade
Authors: Jonathan Riess, David R. Gandara, Garrett Frampton, Mingshan Cheng, Primo Lara, Karen Kelly, Chunting Ye, Russell Madison, Nir Peled, Jose Bufill, Grace Dy, Sai-Hong Ou, Darren Cross, Carol Bult, Susan Airhart, Philip Stephens, Jeffrey Ross, Vincent Miller, Siraj Ali, James Keck, Philipp Mack, Alexa Schrock
Journal: Journal of Thoracic Oncology (2017)
P262 The relationship between penetration or aspiration of oral intake and chest infections in ataxia telangiectasia patients
Authors: CBR Mossey-Gaston, SG Ellum, AC DeSousae, N Oscroft, P Hales, H Baxendale
Journal: Thorax (2016)

<h3>Introduction and objectives</h3> As part of the care of Ataxia Telangiectasia Patients, a baseline swallow profile is obtained using a videofluoroscopy. It was observed that penetration or aspiration of oral intake did not appear to have a direct link to chest infections in these patients. The authors conducted a pilot study, analysing retrospective data to explore this observation further. <h3>Methods</h3> All variant AT patients who attended a multi-disciplinary (MDT) annual review appointment between 01/2013–11/2015 and underwent a videofluoroscopy were included. The patient was ranked on the Penetration Aspiration Score (PAS) from the videofluoroscopy. Retrospective data of the frequency of chest infections requiring treatment with antibiotics in the last 12 months was collected from the annual assessment reports in the medical notes. Initially, 37 patients were included, this was reduced to 30 as 7 videofluoroscopies were not sufficient for calculating the swallow trigger delay. Data was analysed using excel and xlstat (standard descriptive tests and Spearman’s) to evaluate any correlation between aspiration or penetration and number of chest infections. <h3>Results</h3> With a confidence interval of 95%, there was a negative correlation of rs 0.079 (p-value &lt; 0.0001) indicating a very weak correlation. The number of chest infections data was significantly skewed at a result of 2.643. This may be due to the small sample size. <h3>Conclusions</h3> This data suggests there is no correlation between aspiration or penetration and the chest infections experienced by AT Patients. However, this was a small sample due to the rarity of the genetic disorder. A larger sample either through increased length of time that the data is collected or an international study could help provide greater insights into the correlation between aspiration or penetration of oral intake and the number of chest infections experienced. <h3>Reference</h3> Rosenbek JC, Robbins JA, Roeker EB <i>et al</i>. A penetration-aspiration scale. <i>Dysphagia</i> 1996;<b>11</b>(2):93–98.
An Unusual Cause of Small-Bowel Obstruction
Authors: Michael R. Freund, Joseph Weiss Benavid, Petachia Reissman
Journal: JAMA Surgery (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Surgery HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Surgery journal
P45 Non-invasive methods for the estimation of mpap in COPD patients using cardiac mri
Authors: CS Johns, D Capener, C Hammerton, K Shotton, DG Kiely, JM Wild, AJ Swift
Journal: Thorax (2016)

<h3>Background</h3> Pulmonary hypertension (PH) is important in COPD as it predicts death and hospitalisation. The diagnosis is made by right heart catheter (RHC). Several predictive cardiac MRI (CMR) models have been proposed to estimate mean pulmonary artery pressure (mPAP): VMI/IVS: –4.6 + (interventricular septal angle (IVS) x 0.23) + (ventricular mass index (VMI) × 16.3)<sup>1</sup> PA/RV: × 21.806 + (IVS × 0.31) + (VMI × 11.5) + (Diastolic pulmonary artery (PA) area × 0.01) – (PA relative area change × 0.22) Alpha-index: minimum PA area/right ventricular ejection fraction<sup>2</sup> The predictive value of these models in a COPD population with suspected PH remains unknown, so we aimed to assess their diagnostic accuracy. <h3>Methods</h3> All consecutive patients referred to a PH centre from April 2012 to October 2015 with suspected PH were assessed. Any patient with a formal diagnosis of COPD was included. Sensitivity and specificity were calculated using diagnostic cut-offs published in the literature (VMI/IVS = 32, PA/RV model = 25, alpha index = 7.2). Ethical approval was granted. <h3>Results</h3> 1864 patients were referred to the PH centre, 145 had a documented diagnosis of COPD, 102 had MRI and RHC within 90 days. All CMR models showed good correlation with RHC measured mPAP (Pearson’s R for (i) VMI/IVS = 0.689, (ii) PA/RV model = 0.732 and (iii) Alpha-index = 0.527). Sensitivity and specificity for (i) VMI/IVS were 92% and 79%, (ii) PA/RV model 80% and 93% and (iii) for Alpha index 100% and 13% respectively. An ROC curve for the diagnosis of PH for each of the models is provided. <h3>Conclusion</h3> VMI/IVS and PA/RV models both have good accuracy in the detection of PH in COPD patients. Alpha-index had a low specificity, largely due to a low diagnostic threshold. As such these models are useful in the assessment of PH, and likely prognosis in patients with COPD. <h3>References</h3> Swift AJ, <i>et al</i>. Noninvasive estimation of PA Pressure, Flow, and Resistance With CMR Imaging. <i>JACC Cardiovasc Imaging</i> 2013;<b>6</b>(10):1036–47. Moral S, <i>et al</i>. New index alpha improves detection of pulmonary hypertension in comparison with other cardiac magnetic resonance indices. <i>Int J Cardiol</i> 2012;<b>161</b>(1):25–30.
MA08.11 Monitoring the Emergence of EGFR T790M ctDNA in Urine from EGFR Mutated NSCLC Patients to Predict Response to 3rd Generation Anti-EGFR TKIs
Authors: Brian Woodward, Parissa Keshavarzian, Ragi Phillips, Sandeep Pingle, Vlada Melnikova, Mark Erlander, Hatim Husain
Journal: Journal of Thoracic Oncology (2017)
An Analysis of Treatment Choices for Acute Myeloid Leukemia in Patients 60 Years and Older from the University of Duesseldorf AML/MDS Database.
Authors: Viola Klaerner, Andrea Kuendgen, Peter De Porre, Barbara Hildebrandt, Rainer Haas, Norbert Gattermann, Ulrich Germing
Journal: Blood (2007)
P2.03a-029 Efficacy and Safety of Combined Carboplatin, Paclitaxel and Bevacizumab for Patients with Stage IIIb and IV Non-Squamous NSCLC
Authors: Michael Vaslamatzis, Elisavet Patila, Theodoros Tegos, Charalambos Zoumblios, Theodora Kapou, Charalambos Stathopoulos, Nektarios Alevizopoulos, Apostolos Laskarakis, Charalambos Zisis, Edvin Vasili
Journal: Journal of Thoracic Oncology (2017)
In vitro evaluation of biodegradable lignin-based nanoparticles for drug delivery and enhanced antiproliferation effect in cancer cells
Authors: Patrícia Figueiredo, Kalle Lintinen, Alexandros Kiriazis, Ville Hynninen, Zehua Liu, Tomás Bauleth-Ramos, Antti Rahikkala, Alexandra Correia, Tomáš Kohout, Bruno Sarmento, Jari Yli-Kauhaluoma, Jouni Hirvonen, Olli Ikkala, Mauri A. Kostiainen, Hélder A. Santos
Journal: Biomaterials (2017)
PUB040 Treatment Response and Prophylactic Cranial Irradiation Are Important Prognostic Factors in LD SCLC Patients Staged with cMRI
Authors: Chukwuka Eze, Olarn Roengvoraphoj, Maximilian Niyazi, Guido Hildebrandt, Rainer Fietkau, Claus Belka, Farkhad Manapov
Journal: Journal of Thoracic Oncology (2017)
Methylation of the Tumor Suppressor Gene PTPRO (Receptor-Type Protein Tyrosine Phosphatase) Is Associated with Expression of Important Apoptosis-Related Proteins in Chronic Lymphocytic Leukemia (CLL).
Authors: T. Motiwala, K. Ghoshal, S. Majumder, H. Kutay, D. S. Neuberg, S. Kitada, J. C. Reed, G. W. Dewald, I. W. Flinn, M. A. Tallman, T. Liu, C. Plass, D. M. Lucas, J. C. Byrd, S. T. Jacob, M. R. Grever
Journal: Blood (2004)
Identification of Mir-145 and Mir-146a as Micrornas Involved in the Pathogenesis of 5q- Syndrome
Authors: Daniel T. Starczynowski, Florian Kuchenbauer, Bob Argiropoulos, Sandy Sung, Ryan Morin, Andrew L Muranyi, Martin Hirst, Donna E. Hogge, Marco Marra, Richard A. Wells, Wan Lam, R. Keith Humphries, Aly Karsan
Journal: Blood (2008)
Boosts with Highly Purified Stem Cells Can Improve Hematopoietic Regeneration after Allogeneic Transplantation from Alternative Donors.
Authors: Peter Lang, Johann Greil, Markus Koch, Peter Bader, Matthias Pfeiffer, Rebecca Berger, Thomas Klingebiel, Dorothee Wernet, Dietrich Niethammer, Rupert Handgretinger
Journal: Blood (2005)
Studies of Undernutrition, Wuppertal 1946-9
Journal: JAMA (1952)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A guide to systematic review and meta-analysis of prediction model performance
Authors: Thomas P A Debray, Johanna A A G Damen, Kym I E Snell, Joie Ensor, Lotty Hooft, Johannes B Reitsma, Richard D Riley, Karel G M Moons
Journal: BMJ (2017)

Validation of prediction models is highly recommended and increasingly common in the literature. A systematic review of validation studies is therefore helpful, with meta-analysis needed to summarise the predictive performance of the model being validated across different settings and populations. This article provides guidance for researchers systematically reviewing and meta-analysing the existing evidence on a specific prediction model, discusses good practice when quantitatively summarising the predictive performance of the model across studies, and provides recommendations for interpreting meta-analysis estimates of model performance. We present key steps of the meta-analysis and illustrate each step in an example review, by summarising the discrimination and calibration performance of the EuroSCORE for predicting operative mortality in patients undergoing coronary artery bypass grafting.
P1.05-046 Randomized Study of Adjuvant Docetaxel vs. Observation for Completely Resected Stage IB-IIIa NSCLC with 11 Years' Median Follow-Up
Authors: Wen-Zhao Zhong, Xue-Ning Yang, Hong-Hong Yan, Ri-Qiang Liao, Qiang Nie, Song Dong, Ben-Yuan Jiang, Qing Zhou, Jin-Ji Yang, Yi Long Wu
Journal: Journal of Thoracic Oncology (2017)
P124 An investigation into comorbidity accumulation in asthma patients with systemic steroid exposure
Authors: LB Barry, JS Sweeney, C O’Neill, CP Patterson, DP Price, LH Heaney
Journal: Thorax (2016)

<h3>Introduction</h3> Much of the economic cost associated with severe asthma is related to the treatment of comorbidities, several of which arise from systemic steroid exposure related to asthma management. However these comorbidities may not progress equally across age-groups and genders following systemic steroid exposure. <h3>Aim</h3> To examine the relationship between age-groups and gender in relation to prevalence of steroid induced comorbidity and the associated costs. <h3>Methods</h3> Data for a cohort of 808 patients with severe asthma (SA) matched by age and sex with a cohort of 3,975 patients with a diagnosis of mild asthma and 2,412 non-asthma patients with a diagnosis of rhinitis were extracted from the Optimum Patient Care Research Database (OPCRD). Consultation data were used to identify comorbidities and conditional logistic regression analysis provided odds ratios (95% CI’s) for comorbidity risk between cohorts by age-group and gender. Prescription data for individual comorbidities was costed using Prescription Cost Analysis data from Northern Ireland and regressed upon cohort, age and gender. <h3>Results</h3> Results presented below focus on a comparison between the non-asthma and severe asthma cohorts. Compared to older patients, younger patients in the SA cohort show significantly higher odds ratios relative to the non-asthma cohort for many comorbidities (Table 1). Apart from chronic kidney disease, hypercholesterolemia, osteoporosis and osteopenia, males with SA have higher odds ratios for all other comorbidities listed in Table 1 relative to non-asthma patients than females with SA. Upon examination of costs for individual comorbidities, males cost more than females for type II diabetes, hypertension, psychiatric disorders, while the opposite was observed for osteoporosis and osteopenia. Significant linear and non-linear increasing relationships were observed across age for costs related to type II diabetes, hypertension, hypercholesterolemia, dyspeptic disorders, cardiovascular disease, osteoporosis and osteopenia. Furthermore cost differentials for age and gender exhibited varying relationships across morbidities. <h3>Conclusions</h3> The odds of having many steroid-induced comorbidities are higher among younger persons; differences between genders are also evident. While patients’ with SA cost significantly more than patients without steroid exposure or with mild steroid exposure, the distribution of the cost across age and gender varies across comorbidities.
P86 Optimising patient flow and use of resources in the two week wait pathway
Authors: K Goffe, P Ruparelia, CR Sander, C Butler
Journal: Thorax (2016)

<h3>Introduction</h3> Lung cancer is the most common cause of cancer death in the UK. Survival is improving but is worse than in some European countries and North America.¹ NICE guidelines recommend that patients with suspected malignancy are seen within two weeks of referral. An earlier local audit found that 22% of patients referred on the pathway had lung cancer and identified a need to streamline the service. Referrals are triaged as high, intermediate and low risk by a respiratory Consultant based on chest X-ray and clinical details. High-risk patients are prioritised for CT imaging and lung clinical nurse specialist (CNS) time. All patients remain on the two week pathway regardless of triage status. This study reviewed whether this triage system is accurate in identifying patients with malignancy, thereby improving resource utilisation. <h3>Method</h3> Data was collected retrospectively on two week wait referrals during June and July 2015, using referral forms and electronic medical records. Data included key dates in the pathway, triage status and diagnosis. <h3>Results</h3> 25 of 60 patients were triaged as high risk. Thirteen of these patients had cancer. Two patients with lung cancer were not triaged as high risk. Triaging a patient as high risk had a sensitivity for lung malignancy of 86.7% and specificity of 71.4%. Positive predictive value was 0.52. Nineteen patients triaged as high risk had a CT prior to clinician review and the remaining three had a CT within 3 days. This was three times higher than in the low/intermediate group. The CNS attended the majority of initial clinic appointments in prioritised patients, unless CT showed benign disease. <h3>Conclusion</h3> The triage method correctly identified patients with malignancy in the majority of cases. This led to efficient use of resources. Patients with lung cancer had earlier imaging and access to the CNS. Lung cancer symptoms can overlap with other respiratory conditions and following the initial clinical review, the respiratory clinician may decide to investigate some patients less urgently. In future, this method could help stratify urgency of referral. <h3>Reference</h3> Global surveillance of cancer survival 1995–2009: (CONCORD-2). <i>Lancet</i> 2015;<b>385</b>:977–1010.
P2.02-040 Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer
Authors: Hongmei Lin, Yuhchyau Chen, Anhui Shi, Kishan Pandya, Rong Yu, Yannan Yuan, Jiancheng Lin, Hang Li, Yingjie Wang, Tingyi Xia, Linchun Feng, Huimin Ma, Jianhao Gang, Guangying Zhu
Journal: Journal of Thoracic Oncology (2017)
Efficacy of High-Dose Cytarabine Added to Cyclophosphamide/Total-Body Irradiation in the Conditioning Regimen of Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignancy
Authors: Yasuyuki Arai, Kazunari Aoki, June Takeda, Tadakazu Kondo, Tetsuya Eto, Shuichi Ota, Hisako Hashimoto, Takahiro Fukuda, Yukiyasu Ozawa, Yoshinobu Kanda, Chiaki Kato, Mineo Kurokawa, Koji Iwato, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta, Akiyoshi Takami
Journal: Blood (2015)
Immune Reconstitution After Cord Blood Transplantation in Adults Depends on Activity of Thymic Epithelial Cells and Vascular Endothelial Elements,
Authors: Julia Brown, Haesook T Kim, Corey Cutler, Sean McDonough, Edwin Alyea, Vincent Ho, Eyal C. Attar, Bimalangshu R. Dey, Steven L. McAfee, Thomas Spitzer, Robert J Soiffer, Jerome Ritz, Joseph H Antin, Karen K. Ballen, Vassiliki A Boussiotis
Journal: Blood (2011)